Literature DB >> 2963246

Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies.

S Sonis1, A Kunz.   

Abstract

An earlier study by our group reported a frequency of about 40% for oral problems associated with cancer therapy for patients with non-head-and-neck malignancies. Since then, we have instituted a variety of preventive and treatment protocols aimed at the aggressive management of the mouth in patients being treated for malignant disease. In the present study we evaluated the frequency and nature of oral problems associated with cancer treatment in 495 patients treated for non-head-and-neck malignancies between 1978 and 1986. Our analysis indicates that the frequency of oral problems in the study population was 10.5%, compared to 38.7% in 1978. The specific nature and distribution of oral problems by diagnosis, by patient's age, and by type were remarkably consistent. Our results suggest that early and aggressive dental intervention in standardized protocols reduces the frequency of oral problems associated with cancer therapy.

Entities:  

Mesh:

Year:  1988        PMID: 2963246     DOI: 10.1016/0030-4220(88)90184-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  10 in total

1.  Mucositis prevention by improved dental care in acute leukemia patients.

Authors:  Milanko Djuric; Valeria Hillier-Kolarov; Aranka Belic; Ljiljana Jankovic
Journal:  Support Care Cancer       Date:  2005-07-22       Impact factor: 3.603

2.  Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.

Authors:  Naoki Niikura; Katsuhiko Nakatukasa; Takeshi Amemiya; Ken-Ichi Watanabe; Hironobu Hata; Yuichiro Kikawa; Naoki Taniike; Takashi Yamanaka; Sachiyo Mitsunaga; Kazuhiko Nakagami; Moriyasu Adachi; Naoto Kondo; Yasuyuki Shibuya; Naoki Hayashi; Mariko Naito; Kosuke Kashiwabara; Toshinari Yamashita; Masahiro Umeda; Hirofumi Mukai; Yoshihide Ota
Journal:  Oncologist       Date:  2019-10-08

3.  Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome.

Authors:  A B Melkos; G Massenkeil; R Arnold; P A Reichart
Journal:  Clin Oral Investig       Date:  2003-05-24       Impact factor: 3.573

4.  Evaluation of Periodontal Parameters in Patients with Early Stage Chronic Lymphocytic Leukemia.

Authors:  Nives Rinčić; Darko Božić; Goran Rinčić; Petar Gaćina; Darije Plančak
Journal:  Acta Stomatol Croat       Date:  2016-03

Review 5.  Physiological aspects of aging. Implications for the treatment of cancer.

Authors:  S M Lichtman
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

6.  Myelosuppression grading of chemotherapies for hematologic malignancies to facilitate communication between medical and dental staff: lessons from two cases experienced odontogenic septicemia.

Authors:  Masaya Akashi; Yasuyuki Shibuya; Junya Kusumoto; Shungo Furudoi; Yumiko Inui; Kimikazu Yakushijin; Atsuo Okamura; Hiroshi Matsuoka; Takahide Komori
Journal:  BMC Oral Health       Date:  2013-08-19       Impact factor: 2.757

7.  The Therapeutic Effect of PLAG against Oral Mucositis in Hamster and Mouse Model.

Authors:  Ha-Reum Lee; Nina Yoo; Joo Heon Kim; Ki-Young Sohn; Heung-Jae Kim; Myung-Hwan Kim; Mi Young Han; Sun Young Yoon; Jae Wha Kim
Journal:  Front Oncol       Date:  2016-10-17       Impact factor: 6.244

8.  Effects of Onchung-eum, an Herbal Prescription, on 5-Fluorouracil-Induced Oral Mucositis.

Authors:  Jae-Woo Park; Jayoung Oh; Seok-Jae Ko; Mun Seog Chang; Jinsung Kim
Journal:  Integr Cancer Ther       Date:  2018-10-08       Impact factor: 3.279

Review 9.  Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections.

Authors:  J Kanagalingam; R Feliciano; J H Hah; H Labib; T A Le; J-C Lin
Journal:  Int J Clin Pract       Date:  2015-08-06       Impact factor: 2.503

10.  Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.

Authors:  Naoki Niikura; Katsuhiko Nakatukasa; Takeshi Amemiya; Ken-Ichi Watanabe; Hironobu Hata; Yuichiro Kikawa; Naoki Taniike; Takashi Yamanaka; Sachiyo Mitsunaga; Kazuhiko Nakagami; Moriyasu Adachi; Naoto Kondo; Yasuyuki Shibuya; Naoki Hayashi; Mariko Naito; Kosuke Kashiwabara; Toshinari Yamashita; Masahiro Umeda; Hirofumi Mukai; Yoshihide Ota
Journal:  Oncologist       Date:  2019-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.